Medicare Issues Draft Local Coverage Determination (LCD) for Transplant Genomics' TruGraf® Blood Test as Alternative to Surveillance Biopsies

MANSFIELD, Mass., March 29, 2019 /PRNewswire/ -- Transplant Genomics Inc. (TGI) announces that Palmetto GBA has released a draft local coverage determination (LCD) for TruGraf. TruGraf is the first and only non-invasive test validated to rule out subclinical "silent" rejection in kidney...

from PR Newswire: https://ift.tt/2Ub0S9l